| (USD) | Jun 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -7.14M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PBLA returned -99.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -50.0% |
| 1 year | -99.9% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $1,679,986.50 (Dec 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PBLA would be worth today ›No. Panbela Therapeutics, Inc. has not paid a dividend in the past 12 months.
Panbela Therapeutics, Inc. is part of the Healthcare sector.
Panbela Therapeutics, Inc. has a market cap of 485.00 USD, based on the latest quote.